Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
Conditions:   Pulmonary Aspergillosis - Invasive;   Acute Myeloid Leukemia Interventions:   Drug: F901318;   Drug: Caspofungin Sponsors:   F2G Ltd.;   University Hospital of Cologne Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2016 Category: Research Source Type: clinical trials

STRIVE: CD101 Compared to Caspofungin Followed by Oral Step Down Treatment in Subjects With Candidemia
Conditions:   Candidemia;   Mycoses;   Fungal Infection;   FungemiaInterventions:   Drug: CD101 Injection;   Drug: Caspofungin;   Drug: Fluconazole;   Other: intravenous placebo;   Other: oral placeboSponsor:   Cidara Therapeutics Inc.Not yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2016 Category: Research Source Type: clinical trials